BMT CTN Protocol 1204

Reduced-Intensity Conditioning for Children and Adults with Hemophagocytic Syndromes or Selected Primary Immune Deficiencies.

Below are protocol-related documents, which may be periodically updated.

             Protocol Co-Chair: Carl Allen, MD (832-824-4312)

             Protocol Co-Chair: M. Pulsipher, MD

             Protocol Officer: Mary Eapen, MD (414-805-0700)

             Protocol Coordinator: Alyssa Ramirez (301-251-1161)           

             Medical Monitor: Liza Thiel, MD


Accrual for the BMT CTN 1204 trial closed on December 4, 2015.